KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Investing Activities (2018 - 2025)

LifeMD (LFMD) has disclosed Cash from Investing Activities for 8 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 727.39% year-over-year to $17.1 million, compared with a TTM value of $6.9 million through Dec 2025, up 159.88%, and an annual FY2025 reading of $6.9 million, up 159.88% over the prior year.
  • Cash from Investing Activities was $17.1 million for Q4 2025 at LifeMD, up from -$3.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $17.1 million in Q4 2025 and bottomed at -$7.4 million in Q1 2022.
  • Average Cash from Investing Activities over 5 years is -$1.5 million, with a median of -$2.3 million recorded in 2022.
  • The sharpest move saw Cash from Investing Activities tumbled 15000.67% in 2022, then surged 727.39% in 2025.
  • Year by year, Cash from Investing Activities stood at -$1.6 million in 2021, then decreased by 12.2% to -$1.8 million in 2022, then fell by 25.16% to -$2.2 million in 2023, then dropped by 22.74% to -$2.7 million in 2024, then soared by 727.39% to $17.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for LFMD at $17.1 million in Q4 2025, -$3.6 million in Q3 2025, and -$3.7 million in Q2 2025.